A detailed history of Jpmorgan Chase & CO transactions in Heart Beam, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 49 shares of BEAT stock, worth $112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 49 -0.0%
Holding current value
$112
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.8 - $2.94 $88 - $144
49 New
49 $0
Q4 2023

Feb 12, 2024

BUY
$1.13 - $2.5 $9 - $20
8 Added 32.0%
33 $0
Q3 2023

Nov 14, 2023

BUY
$1.93 - $3.26 $48 - $81
25 New
25 $0

Others Institutions Holding BEAT

About HeartBeam, Inc.


  • Ticker BEAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 8,000,870
  • Market Cap $18.3M
  • Description
  • HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a ...
More about BEAT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.